
Wednesday, February 20, 2019—Deep brain stimulation (DBS) with the Medtronic DBS System (Medtronic, Dublin, Ireland) was approved by the Food and Drug Administration (FDA) last year and is now available i…
Wednesday, February 13, 2019—The American Medical Association (AMA) has issued a new Category/Current Procedural Terminology (CPT) code for electrocorticography from an implanted brain neurostimulato…
Monday, February 11, 2019—In an ongoing, open-label extension study of cerliponase alfa (Brineura; BioMarin, San Rafael, CA) for treatment of patients with late infantile neuronal ceroid lipofuscinosis…
Friday, February 08, 2019—The Food and Drug Administration (FDA) has accepted the new drug application (NDA) filing for cenobamate (SK life science; Fair Lawn, NJ), an investigational antiepileptic dru…
Wednesday, February 06, 2019—A new drug application (NDA) has been submitted to the Food and Drug Administration (FDA) for low-dose fenfluramine (Fintepla, previously known as ZX008; Zogenix, Emeryville, …
February 2019—Recognizing NORSE as a clinical presentation is meant to lead to improved research and communication that hopefully may improve outcomes eventually.
February 2019—Extensive workup is necessary when evaluating individuals with seizures and behavioral changes.
Wednesday, January 23, 2019—As part of their Epilepsy Therapy Project, the goal of which is to advance innovation in epilepsy and seizure treatment in a timely manner, The Epilepsy Foundation has awarded…
For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.
Continue »